A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
Clinical trial NCT03361501 · COMPLETED
Trial details
- NCT number
- NCT03361501
- Sponsor
- Grace Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2019-09-24
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.